Showing results (531-540 of 844) with videos related to

Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study GroupJ Bernhard, C Hürny, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)D Crivellari, K N Price, M Hagen, et al.
The Breast Journal|September 30, 2008
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapyClaudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
c-erbB-2 protein expression in node negative breast cancerJ Richner, H A Gerber, G W Locher, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesE Munzone, E Botteri, A Esposito, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
Pageof 85